Follow the team: Juventus has finalized the transaction of Kok Saisan, with a transfer fee of 22 million euros + a bonus of 5 million euros
12:07pm, 15 July 2025Football

reported on July 15 that team reporter Giovanni Albanese reported that Juventus has finalized the deal for Kossan. The agreement reached with Porto is a fixed transfer fee of 22 million euros plus a 5 million euros bonus, some of which are easy to reach. The negotiations have now entered the details stage, and Juventus is preparing to welcome Koon Sesan on the team assembly day on July 24.
Konseisan's own wishes played a decisive role, and he promoted the completion of the deal, and was persuaded by Juventus' plan, especially with coach Tudor on the tactical conception. The talks between the two sides confirmed the complete fit in the philosophy of the competition and the future prospects.
In negotiations with Porto, Rugani may also join the deal, a player Porto is willing to accept. Rugani also worked with coach Farioli in Ajax last season and is becoming a focus of current discussions at both sides' management.
Tỷ số bóng đáRelated Posts
- 0-1! 2-3! Serie A has been unpopular: Lazio + Atlanta loses, 2 teams win away and relegate
- Real Madrid superstar angry at being replaced again in the game
- Champions League semi-finals report: Inter Milan narrowly defeated Barcelona 7-6, Paris eliminated Arsenal 3-1, and the final was held
- Team newspaper: Chelsea is interested in Strasbourg defender Doocure, and the two clubs belong to the same boss
- Manchester United fans are in awesome: Manchester City has no championship again? History may suggest that the Red Devils are going to win the Europa League!
- Haaland s girlfriend posted photos of De Bruyne s farewell party: We will miss you
- Like the Wolves? Roma releases away jerseys for the new season: tailored for those who are with Roma
- Conte brings "anti-drug" to Amorin? Manchester United sells on the 9th and relies on Lukaku to replace him
- Jonatan Ta: Surprised at the sudden recession of Tenhach, there are many top players in the pharmaceutical factory
